Diseases of the skin and subcutaneous tissue (L00-L99)
Excludes 2:
certain conditions originating in the perinatal period (P04-P96) certain infectious and parasitic diseases (A00-B99) complications of pregnancy, childbirth and the puerperium (O00-O9A) congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99) endocrine, nutritional and metabolic diseases (E00-E88) lipomelanotic reticulosis (I89.8) neoplasms (C00-D49) symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94) systemic connective tissue disorders (M30-M36) viral warts (B07.-)
Urticaria and erythema (L49-L54)
Excludes 1:
Lyme disease (A69.2-) rosacea (L71.-)
L49
Exfoliation due to erythematous conditions according to extent of body surface involved [+]
Code first
erythematous condition causing exfoliation, such as: Ritter's disease (L00) (Staphylococcal) scalded skin syndrome (L00) Stevens-Johnson syndrome (L51.1) Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome (L51.3) Toxic epidermal necrolysis (L51.2)
L49.0
Exfoliation due to erythematous condition involving less than 10 percent of body surface Exfoliation due to erythematous condition NOS
L49.1
Exfoliation due to erythematous condition involving 10-19 percent of body surface
L49.2
Exfoliation due to erythematous condition involving 20-29 percent of body surface
L49.3
Exfoliation due to erythematous condition involving 30-39 percent of body surface
L49.4
Exfoliation due to erythematous condition involving 40-49 percent of body surface
L49.5
Exfoliation due to erythematous condition involving 50-59 percent of body surface
L49.6
Exfoliation due to erythematous condition involving 60-69 percent of body surface
L49.7
Exfoliation due to erythematous condition involving 70-79 percent of body surface
L49.8
Exfoliation due to erythematous condition involving 80-89 percent of body surface
L49.9
Exfoliation due to erythematous condition involving 90 or more percent of body surface
L50
Urticaria [+]
Excludes 1:
allergic contact dermatitis (L23.-) angioneurotic edema (T78.3) giant urticaria (T78.3) hereditary angio-edema (D84.1) Quincke's edema (T78.3) serum urticaria (T80.6-) solar urticaria (L56.3) urticaria neonatorum (P83.8) urticaria papulosa (L28.2) urticaria pigmentosa (D47.01)
L50.0
Allergic urticaria
L50.1
Idiopathic urticaria
L50.2
Urticaria due to cold and heat
Excludes 2:
familial cold urticaria (M04.2)
L50.3
Dermatographic urticaria
L50.4
Vibratory urticaria
L50.5
Cholinergic urticaria
L50.6
Contact urticaria
L50.8
Other urticaria Chronic urticaria Recurrent periodic urticaria
L50.9
Urticaria, unspecified
L51
Erythema multiforme [+]
Use additional
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Use additional
code to identify associated manifestations, such as:
Use additional
arthropathy associated with dermatological disorders (M14.8-)
Use additional
conjunctival edema (H11.42)
Use additional
conjunctivitis (H10.22-)
Use additional
corneal scars and opacities (H17.-)
Use additional
corneal ulcer (H16.0-)
Use additional
edema of eyelid (H02.84-)
Use additional
inflammation of eyelid (H01.8)
Use additional
keratoconjunctivitis sicca (H16.22-)
Use additional
mechanical lagophthalmos (H02.22-)
Use additional
stomatitis (K12.-)
Use additional
symblepharon (H11.23-)
Use additional
code to identify percentage of skin exfoliation (L49.-)
Excludes 1:
staphylococcal scalded skin syndrome (L00) Ritter's disease (L00)
L51.0
Nonbullous erythema multiforme
L51.1
Stevens-Johnson syndrome
L51.2
Toxic epidermal necrolysis [Lyell]
L51.3
Stevens-Johnson syndrome-toxic epidermal necrolysis overlap syndrome SJS-TEN overlap syndrome
L51.8
Other erythema multiforme
L51.9
Erythema multiforme, unspecified Erythema iris Erythema multiforme major NOS Erythema multiforme minor NOS Herpes iris
L52
Erythema nodosum
Excludes 1:
tuberculous erythema nodosum (A18.4)
L53
Other erythematous conditions [+]
Excludes 1:
erythema ab igne (L59.0) erythema due to external agents in contact with skin (L23-L25) erythema intertrigo (L30.4)
L53.0
Toxic erythema
Code first
poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4)
Use additional
code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Excludes 1:
neonatal erythema toxicum (P83.1)
L53.1
Erythema annulare centrifugum
L53.2
Erythema marginatum
L53.3
Other chronic figurate erythema
L53.8
Other specified erythematous conditions
L53.9
Erythematous condition, unspecified Erythema NOS Erythroderma NOS
L54
Erythema in diseases classified elsewhere
Code first
underlying disease.
Back to Previous Page
© 2025 - Medicare Informatics - Medicare Informatics & Data Analysis in Cloud
The Provider of Services data are collected through the Centers for Medicare & Medicaid Services (CMS) Regional Offices.
It contains an individual record for each Medicare-approved provider and is updated quarterly.
The Preventive Services information are collected while browsing through the Centers for Medicare & Medicaid Services (CMS) Websites.
Medicare policy changes frequently so links to the source documents have been provided within the document for your reference.
The ICD-10 Diagnosis Codes are based on the latest diagnosis coding files (2021 ICD-10-CM and 2018 GEMs ).
The ICD-10 Procedure Codes are based on the latest procedure coding files (2021 ICD-10-PCS and 2018 GEMs ).